Nadia Roumeliotis
I completed my medical training from McGill University in 2009, my pediatric critical care training from the University of Montreal in 2015, my Masters from the same university in 2015, and my PhD in Clinical Epidemiology & Health Services Research from the University of Toronto in 2021. I am currently a clinician scientist at CHU Sainte-Justine in Montreal. My research focus is on the impacts of pandemic public health restrictions on children/youth, the safety of discharge home from the pediatric critical care unit, and medication errors/adverse drug events in critical care. I am in charge of 'Young Investigators' at the CCCTG.
Recent work
1. Effect of Electronic Prescribing Strategies on Medication Error and Harm in Hospital: a Systematic Review and Meta-analysis.
Roumeliotis N, Sniderman J, Adams-Webber T, Addo N, Anand V, Rochon P, Taddio A, Parshuram C.
J Gen Intern Med. 2019 Oct;34(10):2210-2223. doi: 10.1007/s11606-019-05236-8. Epub 2019 Aug 8. PMID: 31396810
2. A modified Delphi to define drug dosing errors in pediatric critical care.
Roumeliotis N, Pullenayegum E, Rochon P, Taddio A, Parshuram C.
BMC Pediatr. 2020 Oct 21;20(1):488. doi: 10.1186/s12887-020-02384-3. PMID: 33087096
3. Liver enzymes after short-term acetaminophen error in critically ill children: a cohort study.
Roumeliotis N, Pullenayegum E, Taddio A, Rochon P, Parshuram C.
Eur J Pediatr. 2022 Aug;181(8):2943-2951. doi: 10.1007/s00431-022-04502-y. Epub 2022 May 18. PMID: 35585255
4. Discharge Directly Home From the PICU: A Retrospective Cohort Study.
Roumeliotis N, Hassine CH, Ducruet T, Lacroix J.
Pediatr Crit Care Med. 2022 Sep 2. doi: 10.1097/PCC.0000000000003061. Online ahead of print. PMID: 36053070